PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Kollodis BioSciences, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kollodis BioSciences Announces Launch of MAPTrix HyGel, Well Defined Hydrogel for 3D Cell Culture - Kollodis BioSciences, Inc. has announced the launch of its novel MAPTrix HyGel line of products
Kollodis BioSciences Announces Launch of MAPTrix HyGel, Well Defined Hydrogel for 3D Cell Culture

 

NewswireToday - /newswire/ - Malden, MA, United States, 2010/06/03 - Kollodis BioSciences, Inc. has announced the launch of its novel MAPTrix HyGel line of products.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

MAPTrix HyGel is a chemically well-defined product based on Kollodis BioSciences' proprietary recombinant Mussel Adhesive Protein technology. MAPTrix HyGel is an in situ formable hydrogel product designed for 3D (three dimensional) cell culture and related applications.

The MAPTrix hydrogel products are composed of two components: MAPTrix ECM, a mussel adhesive protein based extracellular matrix (ECM) mimetic; and, MAPTrix Linker, a multi-arm polyethylene glycol derivative.

A key difference between MAPTrix based hydrogel products and currently available products is that the MAPTrix hydrogel products allow for the in situ formation of a well-defined three dimensional environment. MAPTrix hydrogel products generate well-defined 3D environments in terms of both biochemical composition; and, physical properties such as pore size and matrix elasticity of the hydrogel under physiological pH conditions. For example, a scientist can readily create a biochemically well-defined three dimensional ECM with use of either a single MAPTrix ECM product or a combination of MAPTrix ECM products. Kollodis currently provides several dozen different MAPTrix products in its MAPTrix ECM line of products.

Due to the extracellular matrix (ECM) derived peptide motifs recombinantly incorporated into Kollodis' mussel adhesive proteins (for example, the RGD structural motif in fibronectin), use of the MAPTrix ECM products can reduce or eliminate the serum requirement necessary for cell culture- as evidenced in primary hepatocyte or neural cell cultures conducted under serum free conditions. Depending upon the end-user's required extracellular protein (or more specifically, the peptide motif responsible for bioactivity), an appropriate MAPTrix ECM product can be selected to in situ create a three dimensional extracellular matrix environment suitable for their cell culture application.

Additionally, scientists can readily fine-tune or engineer the elasticity and/or pore size of the hydrogel by adjusting the concentration of MAPTrix ECM or MAPTrix Linker- particularly when they want to regulate a cell's phenotype with such physical cues as the 3D matrix's elasticity or pore size.

"We are absolutely delighted to commercialize our MAPTrix based hydrogel technology as a breakthrough solution addressing the unmet needs of a chemically defined environment for cell culture, said Louis M. Scarmoutzos, Ph.D., Chief Executive Officer of Kollodis BioSciences. The efficacy of our MAPTrix technology for 3D cell culture was demonstrated in endothelial tube formation. Simply mixing MAPTrix ECM with MAPTrix Linker creates a 3D hydrogel matrix for tube formation within two hours, he added.

About Kollodis BioSciences, Inc.

Kollodis BioSciences, Inc. (kollodis.com) has successfully developed a proprietary recombinant protein expression system for the large scale production of various mussel adhesive proteins (MAP). Kollodis is dedicated to the development, manufacture, and sale of MAP-based smart biomaterials for biotech, medical and industrial applications. The Company's proprietary and patented MAPTrix platform technology recombinantly incorporates bioactive peptides into a mussel adhesive protein (MAP) for cell culture and related applications.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kollodis BioSciences, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kollodis BioSciences Announces Launch of MAPTrix HyGel, Well Defined Hydrogel for 3D Cell Culture

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Sangjae Lee - Kollodis.com 
617-283-2182 info[.]kollodis.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kollodis BioSciences, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kollodis BioSciences, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)